Patton HM - Search Results

1

A link between leptin and steatosis in chronic hepatitis C? Time to weigh up the fats.

Patel K, Muir A, McHutchison JG, Patton HM. Patel K, et al. Among authors: patton hm. Am J Gastroenterol. 2003 May;98(5):952-5. doi: 10.1111/j.1572-0241.2003.07422.x. Am J Gastroenterol. 2003. PMID: 12809813 No abstract available.

2

Primary prophylaxis for spontaneous bacterial peritonitis is linked to antibiotic resistance in the Veterans Health Administration.

Badal BD, Silvey S, Dragilev L, O'Leary JG, Morgan TR, Cheung R, Patel A, Rogal S, Patton H, Nobbe A, Jakab SS, Liu J, Patel N, Bajaj JS. Badal BD, et al. Hepatology. 2023 Jun 1;77(6):2030-2040. doi: 10.1097/HEP.0000000000000184. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36645215

3

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.

Tamaki N, Ahlholm N, Luukkonen PK, Porthan K, Sharpton SR, Ajmera V, Kono Y, Dave S, Ahmed A, Sundaram V, Wilkinson MJ, Patton H, Gupta H, Cervantes V, Hernandez C, Lopez SJ, Loomba R, Baumgartner A, Richards L, Arkkila PE, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. Tamaki N, et al. J Clin Invest. 2022 Nov 1;132(21):e162513. doi: 10.1172/JCI162513. J Clin Invest. 2022. PMID: 36317632 Free PMC article.

4

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N; NASH CRN. Corey KE, et al. Aliment Pharmacol Ther. 2015 Feb;41(3):301-9. doi: 10.1111/apt.13035. Epub 2014 Nov 28. Aliment Pharmacol Ther. 2015. PMID: 25429853 Free PMC article. Clinical Trial.

5

Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.

McCurdy H, Nobbe A, Scott D, Patton H, Morgan TR, Bajaj JS, Yakovchenko V, Merante M, Gibson S, Lamorte C, Baffy G, Ioannou GN, Taddei TH, Rozenberg-Ben-Dror K, Anwar J, Dominitz JA, Rogal SS. McCurdy H, et al. Dig Dis Sci. 2024 Jun;69(6):2008-2017. doi: 10.1007/s10620-024-08409-6. Epub 2024 Apr 14. Dig Dis Sci. 2024. PMID: 38616215

6

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial.

Neuschwander-Tetri BA, Loomba R, Sanyal AJ, Lavine JE, Van Natta ML, Abdelmalek MF, Chalasani N, Dasarathy S, Diehl AM, Hameed B, Kowdley KV, McCullough A, Terrault N, Clark JM, Tonascia J, Brunt EM, Kleiner DE, Doo E; NASH Clinical Research Network. Neuschwander-Tetri BA, et al. Lancet. 2015 Mar 14;385(9972):956-65. doi: 10.1016/S0140-6736(14)61933-4. Epub 2014 Nov 7. Lancet. 2015. PMID: 25468160 Free PMC article. Clinical Trial.

7

Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms.

Nelson JE, Handa P, Aouizerat B, Wilson L, Vemulakonda LA, Yeh MM, Kowdley KV; NASH Clinical Research Network. Nelson JE, et al. Aliment Pharmacol Ther. 2016 Dec;44(11-12):1253-1264. doi: 10.1111/apt.13824. Epub 2016 Oct 11. Aliment Pharmacol Ther. 2016. PMID: 27730688 Free PMC article.

8

Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.

Rogal SS, Taddei TH, Monto A, Yakovchenko V, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John BV, Blechacz B, Cai CX, Gilles H, Shah AS, McCurdy H, Puri P, Jou J, Mazhar K, Dominitz JA, Anwar J, Morgan TR, Ioannou GN. Rogal SS, et al. Clin Gastroenterol Hepatol. 2024 Feb;22(2):324-338. doi: 10.1016/j.cgh.2023.07.002. Epub 2023 Jul 15. Clin Gastroenterol Hepatol. 2024. PMID: 37460005

9

Endogenous versus exogenous fatty acid availability affects lysosomal acidity and MHC class II expression.

Schweitzer SC, Reding AM, Patton HM, Sullivan TP, Stubbs CE, Villalobos-Menuey E, Huber SA, Newell MK. Schweitzer SC, et al. Among authors: patton hm. J Lipid Res. 2006 Nov;47(11):2525-37. doi: 10.1194/jlr.M600329-JLR200. Epub 2006 Aug 16. J Lipid Res. 2006. PMID: 16914769 Free article.

10

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.

Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG. Patton HM, et al. J Hepatol. 2004 Mar;40(3):484-90. doi: 10.1016/j.jhep.2003.11.004. J Hepatol. 2004. PMID: 15123364

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters